• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Incyte Corp Ltd

+ Add to Watchlist


44.5400 USD 0.5600 1.27%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Incyte Corp Ltd (INCY)

Open: 43.9500 Day's Range: 42.9400 - 46.1500 Volume: 3,681,855
Previous Close: 43.9800 52wk Range: 18.2300 - 70.8600 1-Yr Rtn: +105.25%

Stock Chart for INCY

No chart data available.
  • INCY:US 44.5400
  • 1D
  • 1M
  • 1Y
Interactive INCY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INCY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4152
Est. EPS (USD) (12/2014) -0.5450
Est. PEG Ratio -
Market Cap (M USD) 7,373.00
Shares Outstanding (M) 165.54
30 Day Average Volume 2,534,047
Price/Book (mrq) -
Price/Sale (ttm) 18.6194
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INCY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INCY

Incyte Corporation is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. The Company has drug discovery programs underway focused on the identification of new small molecule drugs for cancer and inflammation.

Herve HoppenotPresident/CEORichard U De Schutter "Dick"Non-Executive Chairman
David C HastingsExec VP/CFOJames M Daly "Jim"Exec VP/Chief Commercial Ofcr
More Company Profile & Key Executives for INCY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil